The lectin pathway of the complement system — a system that enhances the body’s ability to clear invaders — may underlie the clinical manifestation of systemic lupus erythematosus (SLE), new research suggests. The study “Mannose-binding lectin serum levels in patients with systemic lupus erythematosus: association with thrombocytopaenia…
A new study reports that eculizumab may be effective in the treatment of certain patients with systemic lupus erythematous (SLE) with renal (kidney) involvement, a condition called lupus nephritis (LN). In the study, “Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence,” published in the journal Rheumatology…
Certain variations in immune-system genes may be associated with an increased risk of Caucasians developing systemic lupus erythematosus (SLE), according to a study The research, “Association between C4, C4A, and C4B copy number variations and susceptibility to autoimmune diseases: a meta-analysis,” was published in Scientific Reports. The immune system…